Camici M
Istituto di Clinica Medica II, Università degli Studi di Pisa.
Clin Ter. 1995 Nov;146(11):713-9.
Present knowledge about biocompatibility during extracorporeal circulation, especially in hemodialysis, has been reported. Clinical implications of membrane biocompatibility on coagulation, fibrinolysis, complement and kalikrein cascade has been analyzed. Particular attention is for the platelet activation in hemodialysis and ist effect upon the coagulation system and dialytic efficiency. The the role of epoprostenol sodium salt (prostacyclin) continous infusion in hemodialysis has been described. Finally future perspectives of anticoagulation during dialytic treatment have been advanced.
关于体外循环期间，尤其是血液透析期间的生物相容性的现有知识已有报道。已分析了膜生物相容性对凝血、纤维蛋白溶解、补体和激肽释放酶级联反应的临床影响。特别关注血液透析中的血小板活化及其对凝血系统和透析效率的影响。已描述了依前列醇钠（前列环素）持续输注在血液透析中的作用。最后，提出了透析治疗期间抗凝的未来展望。
